Treatment of oral chronic graft-versus-host disease with PUVA therapy: Case report and literature review

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 86, Issue 2, 1998, Pages 183-187

  Redding, Spencer W ^a   Callander, Natalie S ^a   Haveman, Carl W ^a   Leonard, Daniel L ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Air Force Materiel Command   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PHOTOSENSITIZING AGENT; PSORALEN DERIVATIVE;

ALLOTRANSPLANTATION; ATROPHY; BONE MARROW TRANSPLANTATION; CASE REPORT; DRUG RESISTANCE; ERYTHEMA; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGY; LEUKOPLAKIA; MALE; MIDDLE AGED; MOUTH DISEASE; MOUTH MUCOSA; MOUTH ULCER; ORAL DRUG ADMINISTRATION; PATHOLOGY; PUVA; REVIEW; XEROSTOMIA;

ADMINISTRATION, ORAL; ATROPHY; BONE MARROW TRANSPLANTATION; DRUG RESISTANCE; ERYTHEMA; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; ORAL ULCER; PHOTOSENSITIZING AGENTS; PSORALENS; PUVA THERAPY; TRANSPLANTATION, HOMOLOGOUS; XEROSTOMIA;

EID: 0032132958     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(98)90123-8     Document Type: Article

References (28)

1. Sullivan KM, Parkman R. The pathophysiology and treatment of graft-versus-host disease. Clinical Haematology 1983;12:775-89.
2. Hood A, Vogelsang G, Black C, Farmer ER, Santos GW. Acute graft-versus-host-disease following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987;123:745-50.
3. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum F, et al. A retrospective analysis of therapy for acute graft versus host disease: initial treatment. Blood 1990;76:1464-72.
4. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992;80:1838-45.
5. Sullivan KM, Shulman HM, Storb R, Weiden PL, McDonald RP, Witherspoon RP, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combined immunosuppression. Blood 1981;57:267-76.
6. Atkinson K. Treatment of extensive human chronic graft-versus-host disease. Hematology 1990;12:681-90.
7. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft versus host disease and other late complications of bone marrow transplantation. Semin Hematol 1991;28:250-9.
8. Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB. Scleroderma, Sjögren-like syndrome, and chronic graft versus host disease. Ann Intern Med 1977;87:707-9.
9. Schubert MA, Sullivan KM. Recognition, incidence and management of oral graft versus host disease. National Cancer Institute Monographs 1990;9:135-43.
10. Schulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft versus host syndrome in man: a long term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
11. Schubert MM, Sullivan KM, Morton TH, Izutsu KT, Peterson DE, Flournoy N, et al. Oral manifestations of chronic graft-versus-host disease. Arch Intern Med 1984;144:1591-5.
12. Heimdahl A, Johnson G, Danielsson KH, Lonnqvist B, Sundelin P, Ringden O. Oral condition of patients with leukemia and severe aplastic anemia. Oral Surg Oral Med Oral Pathol 1985;60:498-504.
13. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziec A, Nagler A. Major salivary gland dysfunction in human acute and chronic graft versus host disease (GVHD). Bone Marrow Transplant 1996;17:219-24.
14. Masaoka T, Shibata H, Kakishita E, Kanamaru A, Takemoto Y, Moriyama Y. Phase II study of FK 506 for allogeneic bone marrow transplantation. Transplant Proc 1991;23:3228-31.
15. Heney D, Norfold DR, Wheeldon J, Bailey CC, Lewis IJ, . Barnard DL. Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol 1991;78:23-7.
16. Woo SB, Lee SJ, Schubert MM. Graft-vs.-host disease. Crit Rev Oral Biol Med 1997;8:201-16.
17. Epstein JB, Truelove EL. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:532-6.
18. Hönigsmann H, Fitzpatrick TB, Pathak MA, Wolf K. Oral photochemotherapy with psoralens and UVA (PUVA): prin-ciples and practice. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freidberg IM, Austen KF, editors. Dermatology in general medicine. 4th ed. Vol 1. New York: McGraw-Hill; 1993. p. 1728-54.
19. Jansin CT, Lehtinin R, Happonin R-P, Lehtinin A, Söderlund K. Mouth PUVA: new treatment for recalcitrant oral lichen planus. Photodermatol 1987;4:165-6.
20. Lundquist G, Forsgren H, Gajechi M, Emtestam L. Photochemotherapy of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:554-8.
21. Keursilehto A, Lehtenin R, Happonen R-P, Heikinheimo K, Lehtimöki K, Jansin CT, et al. An open clinical trial of a new mouth-PUVA variant in the treatment of oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:502-5.
22. Vogelsang GB, Wolff D, Altomonte V, Farmer E, Morison WL, Corio R. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralin (PUVA). Bone Marrow Transplant 1996;17:1061-7.
23. Atkinson K, Weller P, Ryman W, Biggs J. PUVA therapy for drug-resistant graft-versus-host disease. Bone Marrow Transplant 1986;1:227-36.
24. Jampel RM, Farmer ER, Vogelsang GB, Wingard J, Santos GW, Morison WL. PUVA therapy for chronic cutaneous graft-vs-host disease. Arch Dermatol 1991;127:1673-8.
25. Rosso S, Mac Kie R, Zanetti R. Sun exposure, UVA lamps and risk of skin cancer: epidemiological studies. Eur J Cancer 1994;30A:550-2.
26. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997;336:1041-5.
27. Wolff K. Should PUVA be abandoned? N Engl J Med 1997;336:1090-1.
28. Curtis RE, Rowlings PA, Dug JH, Socie G, Travis LB, Horowitz MM, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904.